Key:

• New = recently added manual section

• Reviewed = section content is current

• Revised = section content: may include reporting guidelines, forms, and intervention recommendations

• Updated = web links, agency names, and phone numbers

​

1.0  Introduction  (revised 8/13)

2.0  Map: Districts for Statewide Disease Investigation / Terrorism Response / TB Control  (updated 7/19)

3.0  Communicable Disease Surveillance  (updated 12/14)

4.0  Diseases or Conditions

• Anaplasmosis  (updated 10/24)

• Animal Bites / Injuries  (7/03)

• Anthrax  (revised 2/11)

• Arboviral Disease, Neuroinvasive and Non-Neuroinvasive  (revised 4/15)

  • California Serogroup Viruses, including La Crosse Virus

  • Chikungunya Virus

  • Eatern Equine Encephalitis Virus

  • Powassan Virus

  • St. Louis Encephalitis Virus

  • Venezuelan Equine Encephalitis Virus

  • West Nile Virus

  • Western Equine Encephalitis

• Babesiosis  (revised 7/25)

• Botulism  (revised 2/13)

• Brucellosis  (revised 10/13)

• Campylobacteriosis  (updated 10/23)

• Cholera  (updated 4/12)

• Coccidioidomycosis  (revised 1/12)

• Creutzfeldt-Jakob Disease  (revised 5/16)

• Cryptosporidiosis  (revised 8/11)

• Cyclosporiasis  (revised 10/11)

• Dengue  (revised 7/25)

• Diphtheria  (updated 3/12)

• Escherichia coli O157:H7/Other Hemorrhagic E. coli  (revised 6/11)

• Ehrlichiosis  (updated 10/24)

• Giardiasis  (revised 2/14)

• Haemophilus influenzae, Invasive  (revised 1/15)

• Hansen's Disease (Leprosy)  (revised 4/12)

• Hantavirus Infections  (revised 6/15)

• Hemolytic Uremic Syndrome (HUS), post-diarrheal  (updated 6/24)

• Hemorrhagic Fevers (Viral)  (updated 11/15)

  • Arenaviridae: South American Hemorrhagic Viral Fevers (New World Arenaviruses)

  • Arenaviridae: Lassa Fever (Old World Arenavirus)

  • Bunyaviridae: Crimean-Congo Hemorrhagic Fever

  • Filoviridae: Ebola Hemorrhagic Fever

  • Filoviridae: Marburg Hemorrhagic Fever

• Hepatitis A  (updated 6/23)

• Influenza  (updated 6/17)

• Latent Tuberculosis Infection  (revised 3/14)

• Legionellosis  (revised 2/24)

• Leptospirosis  (updated 11/15)

• Listeriosis  (updated 1/14)

• Lyme Disease  (revised 6/25)

• Malaria  (revised 3/14)

• Measles  (updated 3/25)

• Meningococcal Disease  (updated 7/23)

• Methicillin–resistant Staphylococcus aureus (MRSA)  (5/11)

• Mumps  (revised 8/13)

• Nontuberculous Mycobacterium (NTM) / MOTT  (revised 1/15)

• Outbreak Investigation  (updated 6/24)

• Paragonimiasis  (2/11)

• Perinatal Hepatitis B Case Management Form - PHB 29

• Pertussis  (updated 8/23)

• Plague  (revised 9/12)

• Polio  (updated 5/12)

• Psittacosis  (revised 1/16)

• Q fever  (revised 5/15)

• Rabies, animal  (revised 1/14)

• Rabies, human  (revised 1/14)

• Ricin  (updated 2/13)

• Rocky Mountain Spotted Fever/Spotted Fever Rickettsioses  (updated 10/24)

• Rubella  (revised 11/13)

• Salmonellosis, Nontyphoidal (NTS)  (revised 6/17)

• Shiga toxin-producing E. coli (STEC) and Shiga toxin positive, unknown organism  (revised 6/11)

• Shigellosis  (updated 9/23)

• Streptococcus pneumoniae, Invasive Pneumococcal Disease (IPD)  (new 6/17)

• Streptococcal Toxic Shock Syndrome  (revised 2/16)

• T-2 Mycotoxicosis  (revised 5/16)

• Tetanus  (revised 11/13)

• Toxic Shock Syndrome, Non-Streptococcal  ( revised 5/16)

• Trichinellosis  (revised 4/15)

• Tuberculosis Disease  (revised 3/12)

• Tularemia  (revised 7/25)

• Typhoid & Paratyphoid Fever  (revised 7/15)

• Vaccinia, Adverse Reactions  (revised 4/05)

• Vancomycin-Intermediate Staphylococcus aureus (VISA) and Vancomycin-Resistant Staphylococcus aureus (VRSA)  (5/11)

• Varicella (Chickenpox)  (revised 5/11)

• Vibriosis (non-cholera Vibrio species infections)  (11/12)

• Yellow Fever  (revised 7/25)

• Yersiniosis  (revised 3/12)​​

​